MODS Diagnostic Criteria
Multiple Organ Dysfunction Syndrome (MODS) is diagnosed when two or more organ systems demonstrate dysfunction following an identifiable precipitating event, most commonly assessed using the Sequential Organ Failure Assessment (SOFA) score where a score >5 defines MODS. 1, 2, 3
Core Diagnostic Framework
Primary Requirement
- Identify the precipitating cause (sepsis, trauma, burns, pancreatitis, or other systemic insult) before diagnosing MODS 4
- Two or more organs must demonstrate dysfunction simultaneously or sequentially to meet diagnostic criteria 4, 2
SOFA Score as the Standard Assessment Tool
The SOFA score evaluates six organ systems, each scored 0-4 points (total 0-24), and is the recommended standardized tool for defining and tracking organ dysfunction in critically ill patients. 1, 5
Six Organ Systems Evaluated:
- Score 0: PaO₂/FiO₂ ≥400 mmHg
- Score 1: PaO₂/FiO₂ <400 mmHg
- Score 2: PaO₂/FiO₂ <300 mmHg
- Score 3: PaO₂/FiO₂ <200 mmHg with mechanical ventilation
- Score 4: PaO₂/FiO₂ <100 mmHg with mechanical ventilation
- Score 0: MAP ≥70 mmHg, no vasopressors
- Score 1: MAP <70 mmHg
- Score 2-4: Escalating vasopressor requirements (dopamine, dobutamine, epinephrine, or norepinephrine doses)
- Bilirubin >20.5 μmol/L (>1.2 mg/dL) or albumin <28 g/L indicates dysfunction 4
- SOFA scoring uses bilirubin thresholds: <1.2,1.2-1.9,2.0-5.9,6.0-11.9, >12.0 mg/dL 5
- Creatinine >123.8 μmol/L (>1.4 mg/dL) or urine output <500 mL/24 hours 4
- SOFA uses creatinine levels and urine output thresholds for grading 5
- Platelet count <100 × 10⁹/L 4
- Prolonged or shortened coagulation times (PT, APTT, CT) 4
- SOFA uses platelet thresholds: >150, <150, <100, <50, <20 × 10³/μL 5
- Glasgow Coma Scale ≤14 indicates dysfunction 4
- Altered mental status ranging from indifference to deep coma 4
Gastrointestinal System (in some criteria): 4
- Decreased or absent bowel sounds 4
- Gastric retention, positive occult blood, or hematemesis 4
- Intra-abdominal pressure ≥11 cm H₂O 4
Clinical Severity Stratification
SOFA Score Interpretation for Prognosis: 1, 3
- SOFA 2: Mild single-organ dysfunction with relatively low mortality risk 1
- SOFA >5: Defines MODS; indicates significant organ dysfunction requiring intensive monitoring 3, 1
- SOFA 7-10: Significant multi-organ dysfunction with substantially increased mortality risk 1
- SOFA >10: Predicts mortality exceeding 80-90% 1
- SOFA >11: Associated with >90% mortality 1
Temporal Patterns of MODS
Two distinct clinical phenotypes exist with different prognostic implications: 3
- Early Resolving MODS (ERMODS): SOFA score returns to ≤5 within 7 days; associated with 7% mortality and 41% infection rate 3
- Prolonged MODS (PRMODS): SOFA score remains >5 for >7 days; associated with 22% mortality and 91% infection rate, with more severe hepatic and renal dysfunction 3
Assessment Protocol
- Calculate SOFA score on ICU admission using the most abnormal values from the first 24 hours 1
- Document the precipitating event (sepsis, trauma, pancreatitis, etc.) 4
- Reassess SOFA scores every 48-72 hours throughout ICU stay to track disease progression and treatment response 1
- Increasing SOFA scores indicate worsening prognosis and treatment failure 5
Special Diagnostic Considerations
Sepsis-Related MODS: 1
- In patients with documented or suspected infection, a SOFA score increase ≥2 points from baseline defines sepsis according to Sepsis-3 criteria 1
- This triggers immediate interventions: broad-spectrum antibiotics within 1 hour, fluid resuscitation, and source control 1
Mass Casualty Events: 5
- SOFA scores should be captured systematically for all septic patients during anthrax or other mass-casualty incidents 5
- Real-time organ dysfunction data informs triage decisions and resource allocation 5
Critical Limitations
Do not use SOFA alone for individual triage decisions in non-pandemic settings, as it lacks validation for resource allocation at low scores 1. SOFA does not account for patient age or comorbidities, unlike APACHE II scoring systems 1, 5. The score was designed as a descriptive tool for tracking organ dysfunction over time, not for predicting individual patient outcomes at a single time point 2, 5.